- The FDA has announced a proposal to establish a maximum level of nicotine allowed in cigarettes sold in the U.S.
- As a result, adult smokers in the United States may pursue alternatives, making TAAT an attractive option
- A U.S. patent is pending for the nicotine-free and tobacco-free Beyond Tobacco formulation used to make TAAT products
- TAAT Global Alternatives (TAAT) markets a tobacco-free, and nicotine-free alternative to traditional cigarettes
- TAAT Global Alternatives Inc. (TAAT) opened trading at C$1.20
TAAT Global Alternatives (TAAT) has announced plans to capitalize on a recently announced proposal from the U.S. Food and Drug Administration (FDA).
On June 21, the FDA announced plans to establish a maximum level of nicotine allowed in cigarettes and other combustible tobacco products sold in the U.S.
In the FDA’s announcement, the agency described nicotine’s role in contributing to cigarettes’ addictiveness.
In Q4 2020, TAAT launched its nicotine-free and tobacco-free alternative to tobacco cigarettes in Ohio and rapidly scaled its market position. As of this writing, TAAT is sold under national banners in over 2,700 U.S. retailers, including independent shops and chain stores.
As a result of the FDA’s proposed rule, adult smokers in the United States may pursue alternatives, making TAAT an attractive option to U.S. adult smokers. A U.S. patent is pending for the nicotine-free and tobacco-free Beyond Tobacco formulation used to make TAAT products.
TAAT Founder Joe Deighan commented on the news.
“As a former smoker of tobacco cigarettes, I know nicotine is the enemy. The FDA recognizes this based on its plans to propose a rule to cap the amount of nicotine allowed in tobacco cigarettes sold in the United States. I expect this to cause a considerable shift in the tobacco category in the U.S., which we could capitalize on with our established offering of a nicotine-free alternative that feels substantially similar to a regular cigarette with standard nicotine levels. We continue to commercialize TAAT to build upon our existing footprint of 2,700 U.S. stores and will take proactive steps to take advantage of a new rule such as this if it goes into effect.”
TAAT Global Alternatives (TAAT) markets a tobacco-free and nicotine-free alternative to traditional cigarettes available in “Original,” “Smooth,” and “Menthol” varieties.
TAAT Global Alternatives Inc. (TAAT) opened trading at C$1.20.
